1Education Level Was Missing for 155 (21%) of Individuals

1Education Level Was Missing for 155 (21%) of Individuals

<p>Supplementary Table 1: Characteristics of patients with and without missing data on physical activity in the Seattle Colon Cancer Family Registry, restricted to those with local and regional disease</p><p>Participant characteristics Non-missing Missing p-value (n = 1309) (n = 737) Age at diagnosis (years), Mean (SD) 55.7 (12) 60.4 (10) <0.001 Males, n(%) 710 (54) 301 (41) <0.001 BMI (kg/m2), Mean (SD) 27.6 (6) 28.6 (6) 0.0005 Smoking history, n(%) 0.05 Never 566 (43) 281 (38) Former 532 (41) 314 (43) Current 211 (16) 141 (19) Education level1, n (%) <0.001 <High school 74 (6) 70 (12) High school 305 (23) 190 (33) Some college/vocational school 442 (34) 195 (34) College graduate 488 (37) 127 (21) CRC stage at diagnosis (AJCC), n (%) 0.09 0/I 576 (44) 335 (45) II 260 (20) 168 (23) III 473 (36) 234 (32) Tumor site, n (%) 0.07 Colon 820 (64) 492 (68) Rectal 471 (36) 236 (32) BRAF & KRAS mutation status2, n (%) 0.78 Wildtype 555 (58) 240 (56) BRAF mutated 111 (12) 54 (13) KRAS mutated 283 (30) 130 (30) MSI status5, n(%) 0.12 MSS 880 (85) 448 (82) MSI-H 160 (15) 101 (18)</p><p>CRC Colorectal cancer 1Education level was missing for 155 (21%) of individuals 2671 (32.8%) individuals did not have BRAF-KRAS mutation status evaluated, n = 6 mutated on both BRAF & KRAS dropped 5457 (22.3%) individuals did not undergo testing for MSI status</p><p>1 Supplementary Table 2: Overall and colon cancer-specific survival across categories of prediagnostic physical activity levels (average MET-hours per week) among patients with local and regional disease who had data on at least one tumor molecular characteristica (n=1043)</p><p>Physical activity* Deaths/ Unadjusted Adjusted Model 11 Adjusted Model 22 (MET-h /week) CRC HR (95% CI) HR (95% CI) HR (95% CI) Overall survival <3.5 100/227 REF REF REF 3.5-<8.75 51/204 0.48 (0.34,0.67) 0.53 (0.37,0.74) 0.53 (0.38,0.74) 8.75-<17.5 69/226 0.60 (0.44,0.81) 0.67 (0.49,0.91) 0.65 (0.47,0.88) 17.5-<35 61/216 0.54 (0.39,0.74) 0.61 (0.44,0.84) 0.60 (0.44,0.83) >=35 48/170 0.54 (0.39,0.77) 0.60 (0.42,0.85) 0.59 (0.42,0.84) 3 p-trendoverall 0.001 0.006 0.004 3 p-trendactive 0.70 0.66 0.69</p><p>CRC-specific survival <3.5 56/227 REF REF REF 3.5-<8.75 30/204 0.52 (0.34,0.82) 0.57 (0.36,0.89) 0.58 (0.37,0.90) 8.75-<17.5 34/226 0.55 (0.36,0.83) 0.59 (0.39,0.92) 0.56 (0.37,0.87) 17.5-<35 30/216 0.50 (0.32,0.78) 0.54 (0.35,0.85) 0.53 (0.34,0.84) >=35 22/170 0.47 (0.29,0.77) 0.47 (0.28,0.77) 0.46 (0.28,0.76) 3 p-trendoverall 0.001 0.002 0.001 3 p-trendactive 0.65 0.48 0.43</p><p>CRC Colorectal cancer; MSI Microsatellite instability; HR Hazard ratio; CI Confidence intervals aOf the 1043, 3 had missing data on MSI status and 94 had missing data on BRAF/KRAS status *MET hours per week translated into time equivalent spent walking per week: 3.5 = 1 hour; 8.75 = 2.5 hours; 17.5 = 5 hours; 35 = 10 hours; Topmost percentile of physical activity was excluded 1Adjusted for age at CRC diagnosis, sex, body mass index, smoking status, education and diagnosis year 2Adjusted for age at CRC diagnosis, sex, body mass index, smoking status, education, diagnosis year and stage at diagnosis 3Tests for trend were based on the likelihood-ratio test associated with addition of the categorical physical activity variable in its continuous form (p- trendoverall). We also computed a separate trend test only among those that were physically active (p-trendactive).</p><p>2</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us